Average Co-Inventor Count = 8.11
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (10 from 2,405 patents)
2. Schering Corporation (5 from 1,829 patents)
3. Merck Sharp & Dohme LLC (1 from 6 patents)
4. Schering Coporation (1 from 3 patents)
17 patents:
1. 12497405 - Bicyclic heterocycle compounds methods of use thereof for the treatment of herpes viruses
2. 11752128 - Benzimidazoles and indoles as taro inhibitors
3. 11738010 - Oxazolidinones as TarO inhibitors
4. 11413292 - Tricyclic heterocycle compounds useful as HIV integrase inhibitors
5. 11141403 - Benzimidazoles and indoles as taro inhibitors
6. 11141410 - Oxazolidinones as taro inhibitors
7. 9206142 - Anilinopiperazine derivatives and methods of use thereof
8. 8603998 - Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
9. 8586576 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
10. 8580782 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
11. 8476278 - Thiazole Derivatives as protein kinase inhibitors
12. 8114879 - Piperazine derivatives useful as CCR5 antagonists
13. 7605155 - Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
14. 7384944 - Piperazine derivatives useful as CCR5 antagonists
15. 7196078 - Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors